Breaking News Instant updates and real-time market news.

CERN

Cerner

$70.03

3.35 (5.02%)

, MDRX

Allscripts

$13.94

-0.08 (-0.57%)

07:56
11/24/17
11/24
07:56
11/24/17
07:56

Cerner could get more competitive with Allscripts via Amazon pact, says Leerink

Leerink analyst David Larsen said he thinks Cerner (CERN) and Amazon (AMZN) may already have an existing relationship and the announcement teased in the report by CNBC may be to state that HealtheIntent will rely more heavily on Amazon Web Services. Improvements in Cerner's population health management platform could make it more competitive against Allscripts (MDRX), Quality Systems (QSII) and possibly athenahealth (ATHN), added Larsen, who keeps a Market Perform rating on Cerner shares.

CERN

Cerner

$70.03

3.35 (5.02%)

MDRX

Allscripts

$13.94

-0.08 (-0.57%)

QSII

Quality Systems

$14.47

0.15 (1.05%)

ATHN

athenahealth

$130.23

-0.33 (-0.25%)

AMZN

Amazon.com

$1,156.16

16.67 (1.46%)

  • 28

    Nov

  • 18

    Mar

CERN Cerner
$70.03

3.35 (5.02%)

11/22/17
RBCM
11/22/17
NO CHANGE
Target $74
RBCM
Outperform
Cerner can add credibility with expanded Amazon parternership, says RBC Capital
RBC Capital analyst George Hill commented on the CNBC report that Amazon (AMZN) and Cerner (CERN) will soon announce an expanded partnership focused on Cerner's population health management solution, stating that he thinks the deal would give the company even more credibility when trying to sell its outsourcing or hosting services to large health system clients. The analyst, who doesn't see Amazon getting into the provider interface business near to medium term, doesn't view the deal as a meaningful threat to Cerner, he adds. Hill maintains an Outperform rating and $74 price target on Cerner shares.
11/22/17
STFL
11/22/17
NO CHANGE
STFL
Hold
Amazon pact, as described, would be incremental positive for Cerner, says Stifel
Stifel analyst David Grossman noted the CNBC report claiming that Cerner (CERN) and Amazon Web Services (AMZN) will announce an expanded partnership next week focused on Cerner's population health offering. Such an agreement would allow Cerner to leverage AWS' global reach and technology to scale this business, which is still relatively small but is perceived to be one of the more important and faster growing industry segments, Grossman tells investors. A "much more significant opportunity" would be for Cerner to reduce implementation times and reduce the capital intensity of its business by partnering with a hyperscale cloud provider, like Amazon, added Grossman, who keeps a Hold rating on Cerner shares.
11/02/17
RBCM
11/02/17
DOWNGRADE
Target $74
RBCM
Outperform
Cerner downgraded to Outperform from Top Pick at RBC Capital
RBC Capital analyst George Hill downgraded Cerner to Outperform from Top Pick and lowered his price target to $74 from $84 after a "disappointing" Q3 result and FY18 guidance. Hill notes a bookings miss as a result of some of the deals falling out of Q3 and into Q4. The analyst also sees the initial FY18 EPS implying only 6% growth at the high end.
11/22/17
PIPR
11/22/17
NO CHANGE
Target $70
PIPR
Overweight
Cerner/AWS partnership would be complementary, synergistic, says Piper Jaffray
Commenting on CNBC's report that Amazon Web Services (AMZN) CEO Andy Jassy plans to announce a partnership with Cerner (CERN) to offer population health predictive analytics to providers, Piper Jaffray analyst Sean Wieland says that if they can overcome patient privacy risks, the partnership will be complementary and synergistic. Further, the analyst believes the deal would also validate Cerner as a market leader in Electronic Health Records. Wieland reiterates an Overweight rating and $70 price target on Cerner's shares.
MDRX Allscripts
$13.94

-0.08 (-0.57%)

09/19/17
RBCM
09/19/17
INITIATION
RBCM
Outperform
Allscripts initiated with an Outperform at RBC Capital
RBC Capital analyst George Hill started coverage of Allscripts with a $17 price target and an Outperform rating. He is upbeat on Allscripts as he says that the shares are attractive due to the company's "core business execution, positioning for next generation HCIT solutions, accretion from the EIS acquisition, and valuation." He calls the company "an industry leader in Population Health Management and in revenue cycle management."
09/11/17
COWN
09/11/17
UPGRADE
Target $159
COWN
Outperform
Allscripts upgraded to Outperform from Market Perform at Cowen
Cowen analyst Charles Rihyee upgraded Allscripts to Outperform and increased its price target to $16 from $13 citing improving fundamentals and the EIS acquisition. The analyst said there are a number of drivers not reflected in valuation including mix shifts in the core business towards higher growth areas, incremental earnings and margin expansion from the EIS acquisition, strong free cash flow and capital deployment, and updated guidance that could prove to be conservative.
08/15/17
CANT
08/15/17
UPGRADE
CANT
Overweight
Allscripts upgraded to Overweight from Neutral at Cantor
Cantor analyst Steven Halper upgraded Allscripts (MDRX) to Overweight and raised its price target to $17 from $15 following the acquisition of McKesson's (MCK) EIS business and recent weakness in shares. Halper believes the acquisition price of $185M is attractive and the business can probably fill some important product gaps for Allscripts.
08/14/17
RHCO
08/14/17
NO CHANGE
RHCO
Allscripts outlook positive, says SunTrust
SunTrust analyst Sandy Draper says that Allscripts "will benefit from a stabilized" customer base "and continue to grow its recurring revenue streams." He raised his price target on the stock to $16 from $14 and keeps a Buy rating on the shares.
QSII Quality Systems
$14.47

0.15 (1.05%)

01/05/17
CANT
01/05/17
INITIATION
CANT
Neutral
Quality Systems initiated with a Neutral at Cantor
05/19/17
PIPR
05/19/17
NO CHANGE
Target $16
PIPR
Overweight
Quality Systems 'bleeding has stopped,' outlook stronger, says Piper Jaffray
Piper Jaffray analyst Sean Wieland said after Quality Systems' Q4 report and FY18 guidance that the "bleeding has stopped" for the company and its statements regarding bookings on its earnings call signal a stronger outlook. However, consensus views "remain stubbornly bearish," said Wieland, who sees continued execution and stable results eventually driving a sentiment shift. He keeps an Overweight rating and $16 price target on Quality Systems shares.
08/01/17
PIPR
08/01/17
NO CHANGE
Target $20
PIPR
Overweight
Quality Systems price target raised to $20 from $16 at Piper Jaffray
Piper Jaffray analyst Sean Wieland raised his price target for Quality Systems to $20 from $16 after the company beat on revenue and EPS, and announced the acquisition of a cloud-based analytics platform. With expected bookings acceleration in 2H, improved customer service and a wider platform offering, the analyst believes this sets Quality Systems up for accelerated growth. He reiterates an Overweight rating on the shares.
09/19/17
RBCM
09/19/17
INITIATION
RBCM
Underperform
Quality Systems initiated with an Underperform at RBC Capital
RBC Capital analyst George Hill started coverage of Quality Systems with a $12 price target and an Underperform rating. He thinks that the fundamentals of its HCIT business are unattractive, while its ambulatory business is poised to lose market share.
ATHN athenahealth
$130.23

-0.33 (-0.25%)

10/27/17
PIPR
10/27/17
NO CHANGE
Target $151
PIPR
Overweight
athenahealth provision may 'fan the flames' of speculation, say Piper Jaffray
Piper Jaffray analyst Sean Wieland believes the change in control provisions disclosed this morning by athenahealth could "fan the flames of recent market speculation on a takeout." This should be a positive catalyst for the shares, Wieland tells investors in a research note. He continues to believe a takeout is a possible exit strategy for activist investors. The analyst has an Overweight rating on athenahealth with a $151 price target.
10/25/17
RHCO
10/25/17
NO CHANGE
Target $156
RHCO
Buy
Athenahealth price target lowered to $156 from $170 at SunTrust
SunTrust analyst Sandy Draper lowered his price target on Athenahealth to $156 after Q3 results to reflect a sluggish new business environment and lower physician utilization, which he calls somewhat of a "new normal" for the company. Even with incrementally improving margin, Draper writes in his research note, slower growth outlook justifies a lower multiple. The analyst keeps his Buy rating given the upside in Athenahealth stock price to his new target.
10/23/17
10/23/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. athenahealth (ATHN) upgraded to Equal-Weight from Underweight at First Analysis with analyst Frank Sparacino citing valuation following the company's "disappointing" third quarter results. 2. General Electric (GE) upgraded to Buy from Neutral at BofA/Merrill with analyst Andrew Obin citng the reset in earnings expectations. 3. Dr Pepper Snapple (DPS) upgraded to Outperform from Market Perform at Wells Fargo with analyst Bonnie Herzog saying she has increased confidence in the company's near-term outlook after meeting with management at last week's National Association of Convenience Stores Show. 4. ServiceNow (NOW) upgraded to Overweight from Neutral at Piper Jaffray with analyst Alex Zukin saying channel checks and industry conversations suggest ServiceNow is executing in the near term and "laying the foundation for a multi-year growth story that is still in its early stages." 5. TerraForm Power (TERP) upgraded to Outperform from Neutral at Baird with analyst Ben Kallo saying he believes Brookfield's sponsorship could provide an engine to restore growth. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/23/17
ADAM
10/23/17
NO CHANGE
Target $123
ADAM
Hold
athenahealth price target lowered to $123 from $144 at Canaccord
Canaccord analyst Richard Close lowered his price target on athenahealth to $123 from $144 as he believes the company's future growth may be constrained by bookings challenges and year-over-year decline in volume. Close remains cautious and reiterated his Hold rating on athenahealth shares.
AMZN Amazon.com
$1,156.16

16.67 (1.46%)

11/22/17
NEED
11/22/17
NO CHANGE
Target $86
NEED
Buy
Walgreens Boots Alliance price target lowered to $86 from $94 at Needham
Needham analyst Kevin Caliendo lowered his price target on Walgreens (WBA) to $86, reflecting risk-adjustment from the overhang related to Amazon's (AMZN) pending decision on entering the pharmacy business. The analyst keeps his Buy rating, saying investors may not appreciate the bounce in the company's U.S. retail margin driven in part by the growth of the beauty differentiation program rollout that is still in its early stages.

TODAY'S FREE FLY STORIES

WEN

Wendy's

$15.63

0.24 (1.56%)

, MCD

McDonald's

$173.35

-0.2 (-0.12%)

15:41
12/14/17
12/14
15:41
12/14/17
15:41
Hot Stocks
Chanos says he'd short almost all fast food stocks, except McDonald's »

While being interviewed…

WEN

Wendy's

$15.63

0.24 (1.56%)

MCD

McDonald's

$173.35

-0.2 (-0.12%)

QSR

Restaurant Brands

$61.49

0.16 (0.26%)

YUM

Yum! Brands

$82.12

-0.07 (-0.09%)

JACK

Jack in the Box

$102.49

-0.09 (-0.09%)

SONC

Sonic

$28.32

0.38 (1.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

  • 08

    Jan

  • 08

    Jan

SLM

Sallie Mae

$11.16

-0.45 (-3.88%)

15:40
12/14/17
12/14
15:40
12/14/17
15:40
Options
Sallie Mae sees notable call buying »

Sallie Mae sees notable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

$39.53

0.24 (0.61%)

, PRGO

Perrigo

$82.91

-3.11 (-3.62%)

15:36
12/14/17
12/14
15:36
12/14/17
15:36
Periodicals
Mylan, Perrigo among those interesed in Merck KGaA unit, Bloomberg says »

Mylan (MYL), Perrigo…

MYL

Mylan

$39.53

0.24 (0.61%)

PRGO

Perrigo

$82.91

-3.11 (-3.62%)

MKGAY

Merck KGaA

RBGLY

Reckitt Benckiser

$18.17

0.11 (0.61%)

NSRGY

Nestle

$86.67

0.61 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EADSY

Airbus

$26.16

0.62 (2.43%)

15:34
12/14/17
12/14
15:34
12/14/17
15:34
Periodicals
Airbus COO expected to step down, Reuters reports »

Airbus COO and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JBL

Jabil Circuit

$27.56

-0.99 (-3.47%)

15:34
12/14/17
12/14
15:34
12/14/17
15:34
Options
Jabil Circuit options imply 8.5% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 09

    Jan

MCD

McDonald's

$173.34

-0.21 (-0.12%)

, QSR

Restaurant Brands

$61.42

0.09 (0.15%)

15:32
12/14/17
12/14
15:32
12/14/17
15:32
Hot Stocks
Jim Chanos says not short McDonald's, but is short other fast food stocks »

Chanos, in making…

MCD

McDonald's

$173.34

-0.21 (-0.12%)

QSR

Restaurant Brands

$61.42

0.09 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXPR

Express

$10.30

-0.66 (-6.02%)

15:30
12/14/17
12/14
15:30
12/14/17
15:30
Options
Express calls active as shares see relative weakness »

Express calls active as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

FOXA

21st Century Fox

$32.75

-1.35 (-3.96%)

, DIS

Disney

$111.17

3.555 (3.30%)

15:29
12/14/17
12/14
15:29
12/14/17
15:29
Recommendations
21st Century Fox, Disney analyst commentary  »

21st Century Fox should…

FOXA

21st Century Fox

$32.75

-1.35 (-3.96%)

DIS

Disney

$111.17

3.555 (3.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

  • 15

    Dec

TSLA

Tesla

$339.03

-2 (-0.59%)

15:28
12/14/17
12/14
15:28
12/14/17
15:28
Hot Stocks
Tesla 'already behind' on vehicle autonomy, Chanos says »

Jim Chanos of Kynikos…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

TSLA

Tesla

$339.03

-2 (-0.59%)

15:27
12/14/17
12/14
15:27
12/14/17
15:27
Hot Stocks
Chanos says Tesla CEO Musk 'has broad interpretation of truth' »

Jim Chanos, who is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

BTC

Bitcoin

, BITCOIN

Bitcoin

15:19
12/14/17
12/14
15:19
12/14/17
15:19
General news
Chanos says 'not short' bitcoin but 'speculation' in it indicative of market »

Jim Chanos of Kynikos…

BTC

Bitcoin

BITCOIN

Bitcoin

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$176.83

4.29 (2.49%)

15:19
12/14/17
12/14
15:19
12/14/17
15:19
Options
Adobe options imply 6.2% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

EADSY

Airbus

$26.16

0.62 (2.43%)

15:17
12/14/17
12/14
15:17
12/14/17
15:17
Periodicals
Breaking Periodicals news story on Airbus »

Airbus CEO intends to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

15:17
12/14/17
12/14
15:17
12/14/17
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNK

Mallinckrodt

$23.11

-0.75 (-3.14%)

, ESRX

Express Scripts

$68.57

0.01 (0.01%)

15:16
12/14/17
12/14
15:16
12/14/17
15:16
Periodicals
Chanos says tax bill will affect healthcare more than people think »

Chanos mentioned…

MNK

Mallinckrodt

$23.11

-0.75 (-3.14%)

ESRX

Express Scripts

$68.57

0.01 (0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

$NYE

NYSE Market Internals

15:16
12/14/17
12/14
15:16
12/14/17
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

, SPY

SPDR S&P 500 ETF Trust

$266.05

-0.705 (-0.26%)

15:12
12/14/17
12/14
15:12
12/14/17
15:12
Periodicals
Speaker Ryan says not leaving Congress anytime soon, CBS News reports »

Following a media report…

SPX

S&P 500

SPY

SPDR S&P 500 ETF Trust

$266.05

-0.705 (-0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JCP

J.C. Penney

$2.93

-0.095 (-3.15%)

15:10
12/14/17
12/14
15:10
12/14/17
15:10
Options
Bulls and bears in JC Penney Thursday »

Bulls and bears in JC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCSA

Comcast

$38.58

-0.93 (-2.35%)

, CMCSK

Comcast

15:06
12/14/17
12/14
15:06
12/14/17
15:06
Periodicals
Comcast offered more for Fox assets, but Fox preffered Disney deal, CNBC says »

Sources tell CNBC's…

CMCSA

Comcast

$38.58

-0.93 (-2.35%)

CMCSK

Comcast

FOXA

21st Century Fox

$32.75

-1.35 (-3.96%)

FOX

21st Century Fox

$32.34

-1.26 (-3.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 15

    Dec

COST

Costco

$188.28

-0.02 (-0.01%)

15:04
12/14/17
12/14
15:04
12/14/17
15:04
Options
Costco options imply 5.2% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

VRX

Valeant

$19.22

-2.83 (-12.83%)

15:03
12/14/17
12/14
15:03
12/14/17
15:03
Technical Analysis
Technical View: Valeant near session lows, levels to watch »

The shares are bouncing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 27

    Dec

  • 18

    Jun

CI

Cigna

$204.17

-3.75 (-1.80%)

15:02
12/14/17
12/14
15:02
12/14/17
15:02
Hot Stocks
Cigna announces acquisition of digital health plan platform Brighter »

Cigna announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:00
12/14/17
12/14
15:00
12/14/17
15:00
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

ORCL

Oracle

$50.25

0.195 (0.39%)

14:49
12/14/17
12/14
14:49
12/14/17
14:49
Options
Oracle options imply 7.2% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

DIS

Disney

$111.04

3.43 (3.19%)

, FOXA

21st Century Fox

$32.75

-1.35 (-3.96%)

14:44
12/14/17
12/14
14:44
12/14/17
14:44
Recommendations
Disney, 21st Century Fox analyst commentary  »

RBC Capital sees Disney,…

DIS

Disney

$111.04

3.43 (3.19%)

FOXA

21st Century Fox

$32.75

-1.35 (-3.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

  • 15

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.